News and Trends 23 May 2023
FDA approval for Rznomics’ glioblastoma treatment trial
Rznomics Inc., a South Korea based biopharmaceutical company specializing in the development of RNA-based gene therapeutics, has received phase 1/2a…
RNA technology
- Latest Posts
News and Trends 16 May 2023
SiSaf siRNA therapy gets FDA designations to treat autosomal dominant osteopetrosis
SiSaf Ltd, an RNA delivery and therapeutics company, has announced that SIS-101-ADO, its siRNA therapeutic for patients with autosomal dominant…
News and Trends 5 May 2023
Exothera partners with Quantoom and launches DNA business unit
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The…
News and Trends 27 Apr 2023
Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’
Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference…
ADVERTISEMENT
News and Trends 26 Apr 2023
LincRNA discovery could lead to targeted treatments
Our genetic code includes more than 15,000 specific sections that can be made into molecules called lincRNAs. Some of these…
News and Trends 24 Apr 2023
RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models
Researchers from Tel Aviv University in Israel have revealed details of a new approach to the treatment of ovarian cancer…
News and Trends 11 Apr 2023
Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M
Vitarka Therapeutics, which focuses on non-viral drug delivery technology, has raised £1.27 million ($1.58 million) in equity from venture capital…
News and Trends 24 Mar 2023
Metabolism of RNA linked to leukemia
Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids,…
News and Trends 2 Mar 2023
Partnership formed to develop miRNA to treat pancreatic cancer
RNA delivery and therapeutics company SiSaf Ltd is to collaborate with the University of Leipzig in Germany to develop targeted…
News and Trends 6 Jan 2023
Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
Orbit Discovery Limited has entered into a master service agreement with SanegeneBio Inc., a start-up company dedicated to developing novel…
News and Trends 12 Dec 2022
Japanese research offers hope for Fukuyama muscular dystrophy patients
Fukuyama congenital muscular dystrophy (FCMD) is the second most common form of childhood muscular dystrophy in Japan. The disease manifests…
News and Trends 28 Nov 2022
STORM Therapeutics doses first patient with drug targeting solid tumors
STORM Therapeutics Ltd, announced today that the first patient in a phase 1 study had been dosed with a drug…
News and Trends 23 Nov 2022
BIA and Exopharm sign joint research agreement to develop integrated technology
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working with transformative medicines using exosomes,…
News and Trends 31 Oct 2022
Scientists say RNA production inhibitors important in cancer research
A study by researchers at the Biomedical Institute of Seville (IBIS) and the University of Seville, in collaboration with the…
News and Trends 12 Oct 2022
SiSaf takes steps with FDA for RNA therapeutic to treat rare genetic skeletal disorders
SiSaf Ltd, an RNA delivery and therapeutics company, is initiating the U.S. FDA Regulatory process to obtain orphan drug designation…
News and Trends 12 Oct 2022
Ascidian Therapeutics launches with $50M to rewrite RNA
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, has been launched. With an initial focus…
ADVERTISEMENT
News and Trends 7 Oct 2022
Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines
Ziphius Vaccines, a biopharmaceutical company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent have entered a…
News and Trends 20 Sep 2022
Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy
Regen BioPharma, Inc. has filed a provisional patent application with the USPTO entitled "Dual Checkpoint Inhibitor Aptamer Based Therapeutics." The…
News and Trends 19 Sep 2022
Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a…
News and Trends 12 Sep 2022
SiSaf reveals positive preclinical data in siRNA program to treat osteopetrosis
SiSaf Ltd, an RNA delivery and therapeutics company, has announced positive data confirming safety and efficacy of its Bio-Courier next…
